GetTopicDetailResponse(id=517ce0985b1, topicName=病毒血癥, introduction=病毒血癥, content=null, image=null, comments=3, allHits=703, url=https://h5.medsci.cn/topic?id=70985, type=1, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=10326, tagList=[TagDto(tagId=10326, tagName=病毒血癥)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1799662, encodeId=c79c1e9966260, content=<a href='/topic/show?id=517ce0985b1' target=_blank style='color:#2F92EE;'>#病毒血癥#</a>, objectTitle=NAT MED：HIV-1抗體組合在病毒血癥患者中的安全性評估, objectType=article, longId=149987, objectId=2cad14998e20, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2cad14998e20, replyNumber=0, likeNumber=92, createdTime=2019-03-13, rootId=0, userName=anan, userId=236b481, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2cad14998e20, moduleTitle=NAT MED：HIV-1抗體組合在病毒血癥患者中的安全性評估, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=2cad14998e20)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1799661, encodeId=b2a81e996615e, content=<a href='/topic/show?id=517ce0985b1' target=_blank style='color:#2F92EE;'>#病毒血癥#</a>, objectTitle=J Viral Hepat：恩替卡韋+聚乙二醇干擾素序貫法治療非HBV基因D型的高病毒血癥慢性乙肝療效更佳, objectType=article, longId=24014, objectId=720d2401409, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=720d2401409, replyNumber=0, likeNumber=78, createdTime=2014-07-28, rootId=0, userName=anan, userId=236b481, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=720d2401409, moduleTitle=J Viral Hepat：恩替卡韋+聚乙二醇干擾素序貫法治療非HBV基因D型的高病毒血癥慢性乙肝療效更佳, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=720d2401409)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1799660, encodeId=26c91e9966099, content=<a href='/topic/show?id=517ce0985b1' target=_blank style='color:#2F92EE;'>#病毒血癥#</a>, objectTitle=J HEPATOL：HCV病毒血癥或基因型并不影響HIV/HCV共感染的死亡風險, objectType=article, longId=17585, objectId=340e1e58503, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=340e1e58503, replyNumber=0, likeNumber=88, createdTime=2014-01-22, rootId=0, userName=anan, userId=236b481, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=340e1e58503, moduleTitle=J HEPATOL：HCV病毒血癥或基因型并不影響HIV/HCV共感染的死亡風險, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=340e1e58503)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
